AYTU BIOPHARMA, INC 10-Q filing
Filed 2026-02-03 · Report date 2025-12-31 · 2025
Filing metadata
- Accession number
- 0001437749-26-002804
- Form type
- 10-Q
- CIK
- 0001385818
- Primary document
- https://www.sec.gov/Archives/edgar/data/1385818/000143774926002804/aytu20251231_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AYTU BIOPHARMA, INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $29.1M | - | - |
| Cost Of Revenue | $10.2M | - | - |
| Gross Profit | $18.8M | - | - |
| Operating Income | $-3.5M | - | - |
| Net Income | $-8.6M | - | - |
| Eps Basic | -0.89 | - | - |
| Eps Diluted | -0.89 | - | - |
| Cash And Equivalents | $30.0M | - | - |
| Total Assets | $122.0M | - | - |
| Shareholders Equity | $14.2M | - | - |
| Operating Cash Flow | $3.1M | - | - |
| Capital Expenditures | $17,000 | - | - |